Off-Label Use of Monoclonal Antibodies for Eosinophilic Esophagitis in Humans: A Scoping Review

<b>Background</b>: Eosinophilic esophagitis (EoE) is a rare, chronic immune-mediated disorder with limited treatment options. Despite the U.S. Food and Drug Administration (FDA) approval of dupilumab for EoE, other monoclonal antibodies remain unapproved and are used off-label with limit...

Full description

Saved in:
Bibliographic Details
Main Authors: Benyu Yang, Wenhan Li, Yiqiang Gao, Bo Zhang, Wei Zuo
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/12/11/2576
Tags: Add Tag
No Tags, Be the first to tag this record!